United States Food and Drug Administration (USFDA) has concluded audit at Jubilant Pharmova’s step down subsidiary -- Jubilant Generics. The audit was conducted at Solid Dosage Formulations facility at Roorkee in Uttarakhand of Jubilant Generics. The USFDA has issued six observations pursuant to the completion of the audit. The company will submit an action plan on the observations and will engage with USFDA for next steps.
Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.
